Is AbbVie (abbv) a good stock to buy?

AbbVie (ABBV) closed at $165.99 in the latest trading session, marking a +0.36% move from the prior day. The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe. A couple of potential stocks that you can confidently hold forever are AbbVie (NYSE: ABBV) and Coca-Cola (NYSE: KO).

What was the 52-week low for AbbVie stock?

The low in the last 52 weeks of AbbVie stock was 134.09. According to the current price, AbbVie is 114.60% away from the 52-week low. What was the 52-week high for AbbVie stock? The high in the last 52 weeks of AbbVie stock was 175.91. According to the current price, AbbVie is 87.36% away from the 52-week high.

Does AbbVie (abbv) dip more than broader markets?

AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know. AbbVie (ABBV) closed the most recent trading day at $66.70, moving -1.36% from the previous trading session.

Should you buy AbbVie (abbv) or Coca-Cola (KO)?

A couple of potential stocks that you can confidently hold forever are AbbVie (NYSE: ABBV) and Coca-Cola (NYSE: KO). What makes AbbVie a solid buy-and-hold investment is that the company is diverse, has excellent margins, and generates plenty of free cash flow.